Inactive Instrument

Calendar Organovo Holdings Inc Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-31	Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	CI
04-15	Organovo's fatty liver disease drug meets main goal in mid-stage study	RE

9155b934557.CochpnJ0asTGuLKyUKzWyMnOYFlr9prgopG4zhHbQfg.OOZC3hU9JIqildHiMf-Eq5-qLzZZg__Z1PXpmHutN6dQ2EqfJhIrhp_c4w~23a0284405eb5106ddcd237173e0e7c6

No events available

2024-05-18 12:30	Digestive Disease Week Conference
2024-01-26 18:00	Crohn & Colitis Congress
2023-10-31 12:00	Annual General Meeting
2023-09-11 10:00	H.C. Wainwright Global Investment Conference
2022-10-12 12:00	Annual General Meeting
2022-09-12 07:00	H.C. Wainwright Global Investment Conference
2021-10-05 12:00	Annual General Meeting - Second Call
2021-09-14 12:00	Annual General Meeting
2021-03-08	H.C. Wainwright Global Life Science Conference
2020-09-15 12:00	Annual General Meeting
2020-08-18	Reverse Split: 1 of 20
2020-04-07 13:00	Extraordinary Shareholders Meeting
2020-03-25	Extraordinary Shareholders Meeting - M&A Vote
2019-12-16 08:30	Tarveda Therapeutics Inc. and Organovo Holdings, Inc. Merger Call
2019-09-05 12:00	Annual General Meeting
2019-08-07	Q1 2020 Earnings Release
2019-06-18 13:15	Raymond James Life Sciences & MedTech Conference
2019-05-22 17:00	FY 2019 Earnings Call
2019-05-21	FY 2019 Earnings Release
2019-04-22	Alliance for Regenerative Medicine Cell & Gene Meeting

Fiscal Period	March	2023	2024	2025
Net sales Million USD	Released Forecast Spread	0,00	0,37 0,08 393.33%	0,13
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	0,00	0,00 0,00 -	-15,4
Earnings before Tax (EBT)	Released Forecast Spread	0,00	0,00 0,00 -	0,00
Net income Million USD	Released Forecast Spread	-17,3	0,00 0,00 -	-14,9
EPS USD	Released Forecast Spread	-1,98	-1,98 -1,74 -13.79%	-1,23
Announcement Date		14/07/23	10/05/24	-

Fiscal Period	March	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales Million USD	Released Forecast Spread		0,00 0,08 -	0,01 0,08 -93.33%	0,29 0,08 286.67%	0,03	0,04	0,04	0,03
EBIT Million USD	Released Forecast Spread		-4,12 -4,24 2.9%	-3,68 -4,08 9.83%
Net income Million USD	Released Forecast Spread	-4,03	-3,99 -3,76 -6.28%	-3,60 -3,60 -0.03%
EPS USD	Released Forecast Spread	-0,46	-0,46 -0,43 -6.98%	-0,40 -0,41 2.44%	-0,67 -0,42 -59.52%	-0,33	-0,33	-0,31	-0,26
Announcement Date		10/08/23	09/11/23	08/02/24	10/05/24	-	-	-	-

2024-07-15 01:45	ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21	MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23	SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23	ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23	IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23	ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24	LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00	BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25	PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00	BB BIOTECH AG: Q2 2024 Earnings Release

2024-05-29 16:01	IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00	CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00	EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 17:14	ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00	EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00	BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 16:05	CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-15 07:00	PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14	GNI GROUP LTD.: Q1 2024 Earnings Release
2024-05-14 16:05	KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release